Zeneca Limited v Bayer AG

In the matter of *Zeneca Limited v Bayer AG*, heard before Nancarrow J in the Federal Court of Australia, the dispute concerned the validity and alleged infringement of a patent relating to a novel herbicide. Zeneca Limited, the patentee, alleged that Bayer AG had infringed its patent by manufacturing and selling a herbicide product that incorporated the patented invention. Bayer AG, in turn, challenged the validity of Zeneca's patent on several grounds.

The primary legal issues before the Court were whether the patent was valid, particularly in light of allegations of insufficient disclosure and lack of novelty, and if valid, whether Bayer AG's product constituted an infringement of the patent claims. The Court was required to consider the scope of the patent claims and whether the alleged infringing product fell within that scope, as well as the patentability requirements under the *Patents Act 1990* (Cth).

Nancarrow J's reasoning focused on a detailed analysis of the patent specification and the prior art. The Court applied established principles of patent law concerning the assessment of novelty and inventive step, considering whether the invention as claimed was new and involved an inventive step over what was already known. The Court also examined the sufficiency of the disclosure in the patent, determining whether the patentee had provided a description that was clear and complete enough for a person skilled in the art to perform the invention. The assessment of infringement involved a comparison of the patent claims with the features of Bayer AG's product, applying the principles of literal infringement and, if necessary, the doctrine of equivalents.

The Court found that the patent was valid and that Bayer AG's product infringed the patent. Consequently, orders were made in favour of Zeneca Limited, including an injunction restraining Bayer AG from further infringing the patent and an award of damages.